Latest news
18 March 2019
Primary results from the SAUL study
Prof. Jens Bedke (DE) and Prof. Maria José Ribal discussed the primary results from the SAUL study with Prof. Axel
18 March 2019
Case deliberations: To treat or not to treat with testosterone therapy?
Testosterone therapy (TTH) as a plausible treatment for a patient was examined during “Plenary Session 06: The role of the
18 March 2019
Breaking News Session: Prostate & Bladder Cancer trials
This Monday, the last full day of EAU19 in Barcelona, Prof. Axel Merseburger (DE) presented the results of the SAUL
18 March 2019
Thematic session highlights hot onco-urology updates
Conclusions from recent oncology meetings were summarised during “Thematic Session 11: Latest and hot news in medical treatment in onco-urology”,
17 March 2019
EUT Congress News – Monday 18 March 2019
Read the news and backgrounds from day 3 at EAU19 in Barcelona.
17 March 2019
Daily Debate: Imaging in Urology
Dr. Sanchez-Salas (FR) and Prof. Murphy (AU) discussed recent changes in the diagnostic pathway of clinically localized prostate cancer. In
17 March 2019
OAB: Current options and future challenges
A panel of OAB experts convened in Barcelona on Sunday, presiding over a series of state-of-the-art lectures and case presentations.
17 March 2019
Renal Cell Carcinoma: Controversies in care
“The only thing that is permanent in surgery is change,” remarked Prof. Alexandre Mottrie (BE), launching the first debate in
17 March 2019
Focal therapy: Promising or insufficient?
Focal therapy is a general term for a variety of non-invasive techniques aimed at destroying small tumours inside the prostate,
17 March 2019
Is MRI-targeted biopsy enough?
Opposing views on the efficacy and significance of MRI-targeted biopsy were presented during “Is MRI-targeted biopsy enough?” the first debate
17 March 2019
Breaking News: New PCa drugs and imaging
17 March 2019
EUT Congress News – Sunday 17 March 2019
Read the news and backgrounds from day 2 at EAU19 in Barcelona.
16 March 2019
Plenary Session addresses BCa in young female patients
“Bladder cancer (BCa) is generally considered as a disease of the elderly with a median age approximately 65 to 70